Key figures

Net sales 15.1 EUR, million
Gross margin 68,2 %
EBITDA -1.5 EUR, million
Equity ratio 70,0 %

Share Price
Nasdaq Helsinki Stock Exchange

Interim Report, January – September 2025

Read more

Latest releases

Investor events

Feb 10 - Feb 10, 2026

Financial Statement Bulletin for 1 January – 31 December 2025

May 6 - May 6, 2026

Interim Report for 1 January – 31 March 2026

Aug 14 - Aug 14, 2026

Half-Year Financial Report for 1 January – 30 June 2026

Nov 6 - Nov 6, 2026

Interim Report for 1 January – 30 September 2026

Nov 7 - Nov 7, 2024

Interim Report for 1 January – 30 September 2024

Aug 8 - Aug 8, 2024

Half-Year Financial Report for 1 January – 30 June 2024

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Read more